Provided by Tiger Trade Technology Pte. Ltd.

NEWAMSTERDAM PHARMA CO NV

26.85
-1.0200-3.66%
Post-market: 27.160.3100+1.15%16:49 EDT
Volume:1.15M
Turnover:31.08M
Market Cap:3.21B
PE:-12.52
High:27.97
Open:27.80
Low:26.67
Close:27.87
52wk High:42.21
52wk Low:23.05
Shares:119.54M
Float Shares:92.51M
Volume Ratio:1.41
T/O Rate:1.25%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.1442
EPS(LYR):-1.7211
ROE:-36.81%
ROA:-20.11%
PB:5.08
PE(LYR):-15.60

Loading ...

Aug 14, 2026

Major Issues Report

Form 8-K - Current report
Aug 14, 2026

Major Issues Report

Form 8-K/A - Current report: [Amend]
Aug 06, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Aug 05, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 05, 2026

Major Issues Report

Form 8-K - Current report
Jul 24, 2026

Major Issues Report

Form 8-K - Current report
Jul 22, 2026

Major Issues Report

Form 8-K - Current report
Jun 05, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jun 04, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Jun 03, 2026

Major Issues Report

Form 8-K - Current report
May 26, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 07, 2026

Major Issues Report

Form 8-K - Current report
May 07, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 06, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Apr 24, 2026

Major Issues Report

Form 8-K - Current report
Mar 11, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 06, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 05, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 02, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 02, 2026

Major Issues Report

Form 8-K - Current report